Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1999 Jun;58(6):350–356. doi: 10.1136/ard.58.6.350

Increased vulnerability of postarthritic cartilage to a second arthritic insult: accelerated MMP activity in a flare up of arthritis

J B J van Meurs 1, P L E M van Lent 1, A A J van de Loo 1, A Holthuysen 1, E Bayne 1, I Singer 1, W B van den Berg 1
PMCID: PMC1752891  PMID: 10340959

Abstract

OBJECTIVE—Murine antigen induced arthritis (AIA) is a chronic, smouldering inflammation. Flares of arthritis can be induced by antigen rechallenge or exposure to inflammatory mediators like interleukin 1 (IL1). These flares are characterised by a fast and marked proteoglycan (PG) depletion if compared with the initial arthritis. This study investigated the involvement of metalloproteinases in both the initial and the flare phase of arthritis. 
METHODS—Murine AIA was induced and a flare up of arthritis was induced by injection of 10 ng of IL1β. Messenger RNA levels of MMP-1 and -3 were studied by RT-PCR. MMP activity in cartilage, during both primary AIA as well as the flare up of arthritis, was studied by immunodetection of MMP specific neoepitopes in aggrecan (VDIPEN). Cartilage just before flare induction was analysed for presence of MMPs at the mRNA level as well as at the protein level by zymography.
RESULTS—At the onset of AIA, a fast upregulation of mRNA for stromelysin and collagenase was noted. However, no VDIPEN epitopes were detected during this early phase of arthritis. They appeared when PG depletion was severe at day 7 of arthritis and disappeared when cartilage was repaired. IL1 injection into a knee joint at week 4 of AIA caused a flare up of arthritis, coinciding with a fast and marked PG degradation. This degradation was characterised by accelerated expression of VDIPEN epitopes if compared with the expression in primary AIA. Analysis of cartilage at week 4 of AIA showed still increased mRNA levels of MMP-1 and -3. Moreover, increased levels of latent MMPs were present as well, as APMA activation induced profound VDIPEN epitope. In vitro exposure to IL1 did show increased PG breakdown but no VDIPEN expression, suggesting that factors in addition to IL1 are needed to cause the in vivo VDIPEN expression. 
CONCLUSIONS—The fast and marked PG depletion seen in a flare up of AIA coincides with accelarated expression of MMP induced neoepitopes compared with expression during primary AIA. This accelerated expression is probably linked to increased levels of latent enzyme, which were found to be present in the cartilage before induction of a flare up.



Full Text

The Full Text of this article is available as a PDF (4.9 MB).

Figure 1  .

Figure 1  

Open in a new tab

Semiquantitative mRNA analysis in cartilage during antigen induced arthritis. At several time points after arthritis induction patellar cartilage was collected and RNA was isolated. Semiquantitive mRNA analysis was done using RT-PCR. PCR products were analysed on an ethidium coloured gel. The cycle number at which the product is first detected is taken as a measure for the amount of mRNA present in the original isolated RNA. GAPDH was used to verify that equal amount of RNA were used. Amounts of cycles gene of interest−amount of cycles GAPDH=cycle difference. Control cartilage is taken as a reference point. The experiment was done two times, and each PCR reaction was carried out twice with the same material. Variation between cycle differences was low, at most one PCR cycle.

Figure 2  .

Figure 2  

Open in a new tab

Proteoglycan depletion and VDIPEN expression in primary antigen induced arthritis. Adjacent frontal knee joint sections were stained with safranin O (A, C) and immunostained with anti-VDIPEN (B, D). (A), (B) day 1 of AIA, (C), (D) day 7 of AIA. P=patella, F=femur, bar represents 200 µm. The figure shows absence of VDIPEN expression at day 1 of AIA (B), and pronounced VDIPEN staining at day 7 as indicated by the arrowheads in (D).

Figure 3  .

Figure 3  

Open in a new tab

PG depletion and VDIPEN expression during IL1 induced exacerbation. Ten ng of IL1α was injected into a knee joint of day 28 AIA. Frontal whole knee joint sections were stained with safranin o (A-Cc) and anti-VDIPEN (D-F). At day 28 of AIA no PG depletion and VDIPEN staining was found (A, D). IL1 injection into such a knee joint induced marked PG depletion, which is illustrated in (B) by destaining of the upper cartilage layer, and widespread VDIPEN expression ((E), arrowheads). Repeated IL1 injection into a naive joint, resulted in mild PG depletion (C) and no VDIPEN expression (F). (A), (D) Knee joint of day 28 AIA, bar represents 150 µm. (B), (E) day 1 after IL1 injection into postarthritic knee joint, bar represents 150 µm. (C), (F) day 1 after IL1 injection into a naive knee joint, bar represents 350 µm. P=patella, F=femur.    

Figure 4  .

Figure 4  

Open in a new tab

Increased mRNA levels in postarthritic cartilage. RNA was isolated from cartilage at week 4 of AIA (postarthritic cartilage) and semiquantitative mRNA analysis of several genes was done using RT-PCR. The cycle number at which the product is first detected is taken as a measure for the amount of mRNA present in the original isolated RNA. GAPDH was used to verify that equal amount of RNA were used. Amounts of cycles gene of interest−amount of cycles GAPDH= cycle difference. Contralateral cartilage was used as a reference point. Depicted is the mean (SD) of three separate experiments.

Figure 5  .

Figure 5  

Open in a new tab

Increased gelatinolytic activity in postarthritic cartilage. Pooled extracts of five patellar cartilage layers, were subjected to zymography, using gelatin as a substrate. Postarthritic cartilage was taken at week 4 of AIA and compared with contralateral cartilage. Clear bands on the dark gel indicate gelatinolytic activities. Depicted is a representative example of five separate experiments.

Figure 6  .

Figure 6  

Open in a new tab

Increased amount of latent MMPs in postarthritic cartilage. Patellas of week 4 AIA were incubated with (A) or without (B) APMA ( a known chemical activator of MMPs) in RPMI for 18 hours and cross sections were immunostained for VDIPEN. Bar represents 100 µm. C=cartilage, B=bone.

Figure 7  .

Figure 7  

Open in a new tab

Increased IL1 induced proteoglycan degradation in postarthritic knee joint. Cartilage was pulse labelled with[35S]-sulphate to radiolabel newly formed proteoglycans. Subsequently, labelled cartilage was incubated with 10 ng/ml IL1 for 24 hours. The amount of[35S]-sulphate retained in the cartilage was measured and expressed as a percentage of the[35S]-content of cartilage cultured without IL1. Values are the mean (SD) of nine separate experiments, *=p<0.05 compared with controls, by two tailed Wilcoxon rank sum test.

Figure 8  .

Figure 8  

Open in a new tab

No VDIPEN expression in IL stimulated postarthritic cartilage. Patellas of day 28 AIA were incubated with (A) or without (B) IL1 for 18 hours and cross sections were immunostained for VDIPEN. Bar represents 100 µm. C=cartilage, B=bone.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cawston T. E., Mercer E., de Silva M., Hazleman B. L. Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum. 1984 Mar;27(3):285–290. doi: 10.1002/art.1780270306. [DOI] [PubMed] [Google Scholar]
  2. Firestein G. S., Paine M. M., Littman B. H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 1991 Sep;34(9):1094–1105. doi: 10.1002/art.1780340905. [DOI] [PubMed] [Google Scholar]
  3. Flannery C. R., Lark M. W., Sandy J. D. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem. 1992 Jan 15;267(2):1008–1014. [PubMed] [Google Scholar]
  4. Fosang A. J., Last K., Knäuper V., Murphy G., Neame P. J. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 1996 Feb 12;380(1-2):17–20. doi: 10.1016/0014-5793(95)01539-6. [DOI] [PubMed] [Google Scholar]
  5. Fosang A. J., Last K., Knäuper V., Neame P. J., Murphy G., Hardingham T. E., Tschesche H., Hamilton J. A. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J. 1993 Oct 1;295(Pt 1):273–276. doi: 10.1042/bj2950273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fosang A. J., Neame P. J., Hardingham T. E., Murphy G., Hamilton J. A. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem. 1991 Aug 25;266(24):15579–15582. [PubMed] [Google Scholar]
  7. Fosang A. J., Neame P. J., Last K., Hardingham T. E., Murphy G., Hamilton J. A. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem. 1992 Sep 25;267(27):19470–19474. [PubMed] [Google Scholar]
  8. Gravallese E. M., Darling J. M., Ladd A. L., Katz J. N., Glimcher L. H. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum. 1991 Sep;34(9):1076–1084. doi: 10.1002/art.1780340903. [DOI] [PubMed] [Google Scholar]
  9. Heussen C., Dowdle E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980 Feb;102(1):196–202. doi: 10.1016/0003-2697(80)90338-3. [DOI] [PubMed] [Google Scholar]
  10. Ilic M. Z., Handley C. J., Robinson H. C., Mok M. T. Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys. 1992 Apr;294(1):115–122. doi: 10.1016/0003-9861(92)90144-l. [DOI] [PubMed] [Google Scholar]
  11. Ilic M. Z., Mok M. T., Williamson O. D., Campbell M. A., Hughes C. E., Handley C. J. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid. Arch Biochem Biophys. 1995 Sep 10;322(1):22–30. doi: 10.1006/abbi.1995.1431. [DOI] [PubMed] [Google Scholar]
  12. Ismaiel S., Atkins R. M., Pearse M. F., Dieppe P. A., Elson C. J. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli. Br J Rheumatol. 1992 Jun;31(6):369–373. doi: 10.1093/rheumatology/31.6.369. [DOI] [PubMed] [Google Scholar]
  13. Kozaci L. D., Buttle D. J., Hollander A. P. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum. 1997 Jan;40(1):164–174. doi: 10.1002/art.1780400121. [DOI] [PubMed] [Google Scholar]
  14. Kruijsen M. W., van den Berg W. B., van de Putte L. B. Influence of the severity and duration of murine antigen-induced arthritis on cartilage proteoglycan synthesis and chondrocyte death. Arthritis Rheum. 1985 Jul;28(7):813–819. doi: 10.1002/art.1780280713. [DOI] [PubMed] [Google Scholar]
  15. Kummer J. A., Abbink J. J., de Boer J. P., Roem D., Nieuwenhuys E. J., Kamp A. M., Swaak T. J., Hack C. E. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum. 1992 Aug;35(8):884–893. doi: 10.1002/art.1780350806. [DOI] [PubMed] [Google Scholar]
  16. Lark M. W., Bayne E. K., Flanagan J., Harper C. F., Hoerrner L. A., Hutchinson N. I., Singer I. I., Donatelli S. A., Weidner J. R., Williams H. R. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest. 1997 Jul 1;100(1):93–106. doi: 10.1172/JCI119526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lark M. W., Gordy J. T., Weidner J. R., Ayala J., Kimura J. H., Williams H. R., Mumford R. A., Flannery C. R., Carlson S. S., Iwata M. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J Biol Chem. 1995 Feb 10;270(6):2550–2556. doi: 10.1074/jbc.270.6.2550. [DOI] [PubMed] [Google Scholar]
  18. Lark M. W., Williams H., Hoernner L. A., Weidner J., Ayala J. M., Harper C. F., Christen A., Olszewski J., Konteatis Z., Webber R. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum. Biochem J. 1995 Apr 1;307(Pt 1):245–252. doi: 10.1042/bj3070245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lohmander L. S., Neame P. J., Sandy J. D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 1993 Sep;36(9):1214–1222. doi: 10.1002/art.1780360906. [DOI] [PubMed] [Google Scholar]
  20. McCachren S. S. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 1991 Sep;34(9):1085–1093. doi: 10.1002/art.1780340904. [DOI] [PubMed] [Google Scholar]
  21. McGuire M. B., Murphy G., Reynolds J. J., Russell R. G. Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin. Clin Sci (Lond) 1981 Dec;61(6):703–710. doi: 10.1042/cs0610703. [DOI] [PubMed] [Google Scholar]
  22. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 1997 Mar-Apr;378(3-4):151–160. [PubMed] [Google Scholar]
  23. Okada Y., Takeuchi N., Tomita K., Nakanishi I., Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989 Aug;48(8):645–653. doi: 10.1136/ard.48.8.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Saito S., Katoh M., Masumoto M., Matsumoto S., Masuho Y. Collagen degradation induced by the combination of IL-1alpha and plasminogen in rabbit articular cartilage explant culture. J Biochem. 1997 Jul;122(1):49–54. doi: 10.1093/oxfordjournals.jbchem.a021739. [DOI] [PubMed] [Google Scholar]
  25. Saklatvala J., Pilsworth L. M., Sarsfield S. J., Gavrilovic J., Heath J. K. Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J. 1984 Dec 1;224(2):461–466. doi: 10.1042/bj2240461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sandy J. D., Flannery C. R., Neame P. J., Lohmander L. S. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest. 1992 May;89(5):1512–1516. doi: 10.1172/JCI115742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sandy J. D., Neame P. J., Boynton R. E., Flannery C. R. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J Biol Chem. 1991 May 15;266(14):8683–8685. [PubMed] [Google Scholar]
  28. Shingleton W. D., Hodges D. J., Brick P., Cawston T. E. Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol. 1996;74(6):759–775. doi: 10.1139/o96-083. [DOI] [PubMed] [Google Scholar]
  29. Singer I. I., Kawka D. W., Bayne E. K., Donatelli S. A., Weidner J. R., Williams H. R., Ayala J. M., Mumford R. A., Lark M. W., Glant T. T. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest. 1995 May;95(5):2178–2186. doi: 10.1172/JCI117907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Springman E. B., Angleton E. L., Birkedal-Hansen H., Van Wart H. E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A. 1990 Jan;87(1):364–368. doi: 10.1073/pnas.87.1.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Van Meurs J. B., Van Lent P. L., Joosten L. A., Van der Kraan P. M., Van den Berg W. B. Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis. Rheumatol Int. 1997;16(5):197–205. doi: 10.1007/BF01330296. [DOI] [PubMed] [Google Scholar]
  32. Van Wart H. E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578–5582. doi: 10.1073/pnas.87.14.5578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Walakovits L. A., Moore V. L., Bhardwaj N., Gallick G. S., Lark M. W. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum. 1992 Jan;35(1):35–42. doi: 10.1002/art.1780350106. [DOI] [PubMed] [Google Scholar]
  34. van Beusekom H. J., van de Putte L. B., van den Berg W. B., van den Broek W. J., Buijs W. C. Antigen handling in antigen-induced joint inflammation: kinetics of a second intra-articularly injected dose of antigen in an already established antigen-induced joint inflammation. Immunology. 1981 Sep;44(1):153–161. [PMC free article] [PubMed] [Google Scholar]
  35. van Lent P. L., Holthuysen A. E., van Rooijen N., van de Loo F. A., van de Putte L. B., van den Berg W. B. Phagocytic synovial lining cells regulate acute and chronic joint inflammation after antigenic exacerbation of smouldering experimental murine arthritis. J Rheumatol. 1998 Jun;25(6):1135–1145. [PubMed] [Google Scholar]
  36. van Meurs J. B., van Lent P. L., Singer I. I., Bayne E. K., van de Loo F. A., van den Berg W. B. Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum. 1998 Apr;41(4):647–656. doi: 10.1002/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  37. van de Loo A. A., Arntz O. J., Bakker A. C., van Lent P. L., Jacobs M. J., van den Berg W. B. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am J Pathol. 1995 Jan;146(1):239–249. [PMC free article] [PubMed] [Google Scholar]
  38. van de Loo A. A., Arntz O. J., van den Berg W. B. Flare-up of experimental arthritis in mice with murine recombinant IL-1. Clin Exp Immunol. 1992 Feb;87(2):196–202. doi: 10.1111/j.1365-2249.1992.tb02974.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van den Berg W. B., Kruijsen M. W., van de Putte L. B., van Beusekom H. J., van der Sluis-van der Pol M., Zwarts W. A. Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death. Br J Exp Pathol. 1981 Jun;62(3):308–316. [PMC free article] [PubMed] [Google Scholar]
  40. van der Zee E., Everts V., Hoeben K., Beertsen W. Interleukin-1 alpha and epidermal growth factor synergistically enhance the release of collagenase by periosteal connective tissue in vitro. Matrix. 1993 Sep;13(5):389–398. doi: 10.1016/s0934-8832(11)80044-2. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES